Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-17

Clinical Trial Update: Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating a combination chemotherapy regimen (carboplatin, melphalan, etoposide phosphate, mannitol, and sodium thiosulfate) in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Etoposide phosphate (etoposide phosphate)
  • Mannitol (mannitol)
  • Melphalan (Melphalan)
  • Sodium thiosulfate (sodium thiosulfate)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma | Phase 1, Phase 2 | Status: COMPLETED